Apple downgraded, HPE upgraded: Wall Street's top analyst calls

Moby summary of KESTRA MEDICAL TECHNOLOGIES, LTD.'s Q4 2026 earnings call

Despite a significant net loss, Kestra Medical Technologies Ltd (KMTS) reports robust revenue growth and strategic advancements in sales territories and product innovation.

Kestra Medical Technologies (NASDAQ:KMTS) reported a sharp increase in fourth-quarter revenue and issued fiscal 2027 guidance calling for continued growth, as executives said demand for the company’s ASSURE wearable cardioverter defibrillator system is being driven by new accounts, deeper penetratio

Kestra Medical Technologies, Ltd. (KMTS) delivered earnings and revenue surprises of -13.56% and +8.05%, respectively, for the quarter ended April 2026. Do the numbers hold clues to what lies ahead for the stock?

Kestra Medical Technologies (KMTS) has drawn investor attention after recent trading left the stock about 23% lower over the past month and roughly 28% lower over the past 3 months. See our latest analysis for Kestra Medical Technologies. With the share price at US$19.46, the stock has a 7 day share price return of 1.9%. However, the 30 day and year to date share price returns of about 23% and 20% declines point to fading short term momentum, despite a 1 year total shareholder return of...

Kestra Medical Technologies (NASDAQ:KMTS) reported what management described as a strong third quarter of fiscal 2026, highlighted by higher prescriptions, accelerating revenue growth, and continued gross margin expansion as the company scales its wearable cardioverter defibrillator (WCD) business a

Moby summary of KESTRA MEDICAL TECHNOLOGIES, LTD.'s Q3 2026 earnings call

Kestra Medical Technologies Ltd (KMTS) reports a 63% revenue increase, despite ongoing net losses and strategic investments in market expansion.

This article first appeared on GuruFocus. Kestra Medical Technologies Ltd (NASDAQ:KMTS) is set to release its Q3 2026 earnings on Mar 17, 2026. The consensus estimate for Q3 2026 revenue is $22.86 million, and the earnings are expected to come in at -$0.60 per share.